SCHEMBL16601908

SCHEMBL16601908

O=C(/C=C/c1ccc(OCO)c(OCO)c1)OCCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 4/20 0.72
AKR1B10 O60218 6/20 0.66
AKR1B1 P15121 6/20 0.66
ALOX5 P09917 4/20 0.66
CYP3A4 P08684 2/20 0.66
ALOX15 P16050 2/20 0.66
ALOX12 P18054 2/20 0.66
MAPK1 P28482 2/20 0.66
HSD17B10 Q99714 2/20 0.66
AKR1C3 P42330 2/20 0.66
KDM4E B2RXH2 1/20 0.66
MEN1 O00255 1/20 0.66
GMNN O75496 1/20 0.66
ALDH1A1 P00352 1/20 0.66
EGFR P00533 1/20 0.66
LMNA P02545 1/20 0.66
ESR1 P03372 1/20 0.66
ERBB2 P04626 1/20 0.66
APP P05067 1/20 0.66
LCK P06239 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16601907 0.93 AKR1B10 (0.65) TTRAKR1B10AKR1B1ALOX5CYP3A4
SCHEMBL2602742 0.88 TTR (0.69) TTRAKR1B10AKR1B1ALOX5CYP3A4
SCHEMBL16601909 0.88 CA12 (0.65) TTRAKR1B10AKR1B1AKR1C3KDM4E
SCHEMBL18534005 0.87 TTR (0.74) TTRAKR1B10AKR1B1ALOX5KDM4E
SCHEMBL14113938 0.84 TTR (1.00) TTRAKR1B10AKR1B1ALOX5CYP3A4
SCHEMBL15378926 0.82 TTR (0.74) TTRAKR1B10AKR1B1ALOX5CYP3A4
SCHEMBL2602745 0.82 TTR (0.74) TTRAKR1B10AKR1B1ALOX5CYP3A4
SCHEMBL2602740 0.81 AKR1B10 (0.63) TTRAKR1B10AKR1B1ALOX5CYP3A4
SCHEMBL18534004 0.81 CA12 (0.73) TTRAKR1B10AKR1B1KDM4EALDH1A1
SCHEMBL2605865 0.80 TTR (0.71) TTRAKR1B10AKR1B1ALOX5CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9040579-B2 Combination therapy using coenzyme Q10 and a caffeic acid-derived ester Chemigen (US) 2015-05-26 US disclosed
US-8993621-B2 Caffeic acid derivatives and their use in improving neuronal cell viability CHEMIGEN, INC. (US) 2015-03-31 US disclosed